Document is current
Any future updates will be listed below
-
Authors
Nieman, Lynnette K. https://orcid.org/0000-0003-0534-8025
Castinetti, Frederic https://orcid.org/0000-0002-1808-8800
Newell-Price, John https://orcid.org/0000-0002-0835-5493
Valassi, Elena https://orcid.org/0000-0002-3864-0105
Drouin, Jacques
Takahashi, Yutaka https://orcid.org/0000-0002-1337-9246
Lacroix, André https://orcid.org/0000-0003-4137-3025
- License Information
-
More Information
Article History
Accepted: 12 December 2024
First Online: 23 January 2025
Competing interests
: J.N.-P. has received research support and consultancy paid to his institution from Recordati Rare Diseases, Crinetics Pharmaceuticals and Sparrow Pharmaceuticals, and is President of the Endocrine Society. F.C. received research grants and honoraria for expert advice from Recordati Rare Diseases, HRA Pharma Rare Diseases and Lundbeck. Y.T. has received honoraria from Novo Nordisk, Recordati Rare Diseases, Otsuka Pharma and Ascendis. A.L. has received research grants from Pfizer Canada and Recordati Canada Rare Diseases, serves on an advisory board for Recordati Canada Rare Diseases, is on a speakers bureau for Medunik Canada, and has spoken on behalf of Recordati Canada Rare Diseases; he receives royalties for work as an editor of the adrenal section of UpToDate and Encyclopedia of Endocrine Diseases, and is an inventor on a patent for endocrine diseases related to KDM1A for work performed at the Universite Paris–Saclay. L.K.N. receives royalties as an author and editor for UpToDate and has received research support paid to her institution from Crinetics Pharmaceuticals. E.V. received honoraria for consulting, lectures and advisory boards from HRA Pharma and Recordati Rare Diseases. J.D. declares no competing interests.
